Intellia Therapeutics (NTLA) Return on Capital Employed [ROCE] (2016 - 2026)
Intellia Therapeutics (NTLA) recorded Return on Capital Employed [ROCE] of -58.12% in Q2 2026, up 2.32 percentage points from -60.45% a year earlier but down 0.01 percentage points from the prior quarter.
Powered by 
Analysis
Intellia Therapeutics (NTLA) Return on Capital Employed [ROCE] (2016 - 2026) Analysis & Trends
For FY2025, Intellia Therapeutics reported Return on Capital Employed [ROCE] of -48.32%, down 1.25 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] has declined for five straight years, with a five-year change of -17.35 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Capital Employed [ROCE] came in at -47.07% in FY2024 (-7.29 pp), -39.78% in FY2023 (-4.01 pp), -35.77% in FY2022 (-4.61 pp) and -31.16% in FY2021 (-0.19 pp).
- Quarterly Return on Capital Employed [ROCE] has ranged from -60.45% in Q2 2025 to -22.53% in Q4 2021 over the past five years.
- On a year-over-year basis, Return on Capital Employed [ROCE] rose in 1 of the last eight quarters, with an average year-over-year change of -6.93 percentage points.
- Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 4.61 percentage points in Q4 2021, against a drop of 18.98 percentage points in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at -58.11% (Q1 2026), -56.55% (Q4 2025) and -58.50% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Intellia Therapeutics | 1.57 Bn | -171.10 Mn | - | -54.32% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -54.32% |
| Jun 30, 2026 | -58.12% |
| Mar 31, 2026 | -58.11% |
| Dec 31, 2025 | -56.55% |
| Sep 30, 2025 | -58.50% |
| Jun 30, 2025 | -60.45% |
| Mar 31, 2025 | -55.44% |
| Dec 31, 2024 | -49.87% |
| Sep 30, 2024 | -49.94% |
| Jun 30, 2024 | -46.77% |
| Mar 31, 2024 | -43.75% |
| Dec 31, 2023 | -44.54% |
| Sep 30, 2023 | -40.75% |
| Jun 30, 2023 | -36.19% |
| Mar 31, 2023 | -31.19% |
| Dec 31, 2022 | -38.97% |
| Sep 30, 2022 | -44.34% |
| Jun 30, 2022 | -38.24% |
| Mar 31, 2022 | -32.58% |
| Dec 31, 2021 | -22.53% |
API Access
Intellia Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();